Pressured to help other countries in the fight against the health crisis, the United States said on Tuesday (4) that part of this support could come to Brazil – that it exceeded 411 thousand deaths due to Covid-19 and has just faced two months most lethal of the pandemic.
The White House has announced that it is working to send $ 20 million in drugs used to intubate patients with Covid-19.
According to spokeswoman Jen Psaki, the items will come out of the strategic stockpile of the American government and will be delivered in partnership with the Pan American Health Organization.
She did not provide further details on when the submission should take place and said that the matter has not been finalized, but that it is an “ongoing effort”. The support is to “compensate for global supply surges” and allow Brazil to receive enough medicines for its immediate needs, said Psaki.
The announcement comes a week after Joe Biden’s government confirmed the sending of inputs for the production of vaccines, tests, medicines, mechanical respirators and personal protective equipment to India.
The Asian country has become the third country in the world ranking of deaths – behind only Brazil and the USA – and is experiencing a collapse in its health system, with a lack of beds and oxygen, and a queue to cremate its dead. India has more than 222,000 deaths, according to official data, which many consider highly underestimated.
With a population of 1.3 billion, the second largest in the world, second only to China, and the emergence of a new variant, B.1.617, now dominant among cases in the country, the uncontrolled pandemic is a cause for concern.
The new strain is being investigated to find out if it is more dangerous than the original form of the virus, but its rapid spread across India and 16 other countries is already a concern.
From a political point of view, however, India is part of the Quad — an abbreviation for Quadrilateral Security Dialogue— a partnership with Japan, Australia and the United States to combat the expansion of China, which has also struck deals to help other nations with vaccine delivery and supplies, as part of the pandemic geopolitics race.
Later on Tuesday, the American president indicated, during a news conference, that Brazil may be among the countries that will receive immunizations that are left in the US – the country announced last week that it would release up to 60 million doses of the AstraZeneca vaccine. .
The immunizer, manufactured in partnership with the University of Oxford, has not yet been approved in the United States. So far, the country is vaccinating its population with products from three manufacturers – Pfizer / BioNTech, Moderna and Johnson & Johnson.
When making the announcement, the Democratic administration did not say which countries would be listed to receive the doses, but when asked by a GloboNews journalist this Tuesday about the criteria for distribution and whether Brazil and India would be on this list, the president opened up the possibility deliver immunizers to the Brazilian government.
“With regard to the Astrazeneca vaccine we have, we sent it to Canada and Mexico and we are talking to other countries. In fact, I spoke to a head of state today. I am not ready to announce to whom else we will send the vaccine too, but we will have sent it 10% of what we have until July 4th for other nations, including some of the ones you mentioned, “said Biden.
The Brazilian government has been criticized for failing to speed up vaccination, among other reasons due to the delay in delivering ready-made doses and supplies for manufacturing in the country.
Brazil even consulted in the past on the possibility of receiving the surplus from AstraZeneca in the USA, but the answer was that the American government would prioritize the immunization of its own population.
The shipment of about 4 million units of AstraZeneca’s immunizer to Canada and Mexico – 1.5 million and 2.5 million doses for each, respectively – was announced in March.
In relation to the Mexican government, the sending of vaccines was seen as a way of stroking the country to tighten controls on the border with the United States, which is experiencing a serious migratory crisis and the largest flow of immigrants from Mexico in 20 years.
The AstraZeneca immunizer had its safety questioned after the registration of rare cases of clots in Europe. European countries have come to suspend or restrict use. The European Union regulatory agency (EMA), however, concluded that the vaccine’s benefits outweigh its potential risks and recommended that the bloc’s governments keep the applications, adding a warning to the product package insert.